Proteomic profiling of advanced hepatocellular carcinoma identifies predictive signatures of response to treatments
Frédéric Saltel, Adèle Delamarre, Marie Decraecker, Jean‐Frédéric Blanc, Cyril Dourthe, Jean‐William Dupuy, Isabelle Mahouche, Nathalie Allain, Julie Giraud, Benoı̂t Pinson, P. Biolac-Sage, Jérôme Boursier, Paulette Bioulac-Sage, Anne‐Aurélie Raymond, Audrey Morisset, , Anne-Aurélie Raymond
This study identifies proteomic signatures predictive of treatment response in advanced hepatocellular carcinoma using mass spectrometry and machine learning.
ESMO Open · Sep 1, 2025Peer-reviewedCancer Biology